Literature DB >> 3265909

Expression of a cloned human interleukin-2 cDNA is enhanced by the substitution of a heterologous mRNA leader region.

B R Cullen1.   

Abstract

A cloned interleukin-2 (IL-2) cDNA was poorly expressed in transfected eukaryotic cells. This low expression was only partly relieved by removal of the homopolymer tail present in the 5' leader region of the encoded IL-2 mRNA. However, replacement of the natural IL-2 mRNA 5' noncoding region with a leader element derived from the efficiently translated rat preproinsulin II mRNA resulted in an mRNA molecule that was utilized effectively by the transfected cell. The enhanced expression of this chimeric IL-2 mRNA did not appear to be due to changes in the sequence near the translation initiation codon. These results suggest that the leader elements of efficiently translated mRNAs may be able to confer a higher translational efficiency on heterologous protein coding regions when present in cis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265909     DOI: 10.1089/dna.1988.7.645

Source DB:  PubMed          Journal:  DNA        ISSN: 0198-0238


  8 in total

1.  The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop.

Authors:  T M Ross; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

2.  Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.

Authors:  R B Gayle; C R Maliszewski; S D Gimpel; M A Schoenborn; R G Caspary; C Richards; K Brasel; V Price; J H Drosopoulos; N Islam; T N Alyonycheva; M J Broekman; A J Marcus
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

3.  Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase.

Authors:  J Bielicki; M Fuller; X H Guo; C P Morris; J J Hopewood; D S Anson
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

4.  Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes.

Authors:  H S Scott; T Litjens; P V Nelson; P R Thompson; D A Brooks; J J Hopwood; C P Morris
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

5.  Post-transcriptional regulation in higher eukaryotes: the role of the reporter gene in controlling expression.

Authors:  D R Gallie; J N Feder; R T Schimke; V Walbot
Journal:  Mol Gen Genet       Date:  1991-08

6.  Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase.

Authors:  D S Anson; J A Taylor; J Bielicki; G S Harper; C Peters; G J Gibson; J J Hopwood
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

7.  Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.

Authors:  B Gansbacher; K Zier; B Daniels; K Cronin; R Bannerji; E Gilboa
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

8.  Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.

Authors:  J Connor; R Bannerji; S Saito; W Heston; W Fair; E Gilboa
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.